Scott Conley focuses his practice on patent prosecution, portfolio management and freedom to practice analysis, with a particular emphasis on patents in the biotechnology, chemical and pharmaceutical sectors. He has extensive academic and industrial research experience, which allows him to understand complex chemical issues and to effectively communicate with scientists and clients throughout the patent process, both in the U.S. and internationally.
